Serotonergic involvement in phencyclidine-induced behaviors.

Area of Science:

• Neuroscience
• Pharmacology
• Behavioral Science

Background:

• Phencyclidine (PCP) is a dissociative anesthetic known to induce behavioral changes.
• The role of serotonin (5-HT) in PCP-induced behaviors is not fully understood.
• Investigating the neurochemical mechanisms underlying PCP's effects is crucial for understanding its psychotomimetic properties.

Purpose of the Study:

• To investigate the involvement of serotonin (5-HT) in phencyclidine (PCP)-induced stereotyped behaviors in rats.
• To elucidate the effects of PCP on central serotonergic neurotransmission.
• To determine the relationship between PCP-induced behaviors and alterations in 5-HT levels and metabolism.

Main Methods:

• Administration of phencyclidine (PCP) at doses of 5-10 mg/kg to rats.
• Assessment of PCP-induced stereotyped behaviors (sniffing, backpedalling, head weaving, turning).
• Pharmacological manipulation using 5-HT depleters, precursor, releaser, antagonist, MAO inhibitor, and reuptake inhibitor.
• Measurement of 5-HT and 5-HIAA levels in discrete brain regions (striatum, thalamus/hypothalamus).

Main Results:

• PCP administration induced stereotyped behaviors in rats.
• These behaviors were attenuated by 5-HT depleters and a 5-HT receptor antagonist.
• PCP increased 5-HT content in the thalamus/hypothalamus and affected 5-HIAA levels, indicating altered serotonergic activity.
• PCP also prevented 5-HT depletion by PCA, suggesting a role in 5-HT release or reuptake inhibition.

Conclusions:

• PCP-induced stereotyped behaviors are significantly associated with serotonergic neuronal activity.
• The drug appears to influence behaviors through both 5-HT releasing and reuptake inhibitory actions.
• These findings highlight the critical role of the serotonin system in mediating the complex behavioral effects of PCP.